Alle verbonden artikelen

Isolation of adipose derived stromal cells without enzymatic treatment: expansion, phenotypical and functional characterization.

Auteurs : Busser H, De Bruyn C, Urbain F, Najar M, Pieters K, Raicevic G, Meuleman N, Bron D, Lagneaux L
Jaar : 2014
Journal : Stem Cells Dev.
Volume : 23(19)
Pagina's : 2390-2400

International study on inter-reader variability for circulating tumor cells in breast cancer.

Auteurs : Ignatiadis M, Riethdorf S, Bidard FC, Vaucher I, Khazour M, Rothé F, Metallo J, Rouas G, Payne RE, Coombes RC, Teufel I, Andergassen U, Apostolaki S, Politaki E, Mavroudis D, Bessi S, Pestrin M, Di Leo A, Campion M, Reinholz M, Perez E, Piccart-Gebhart M, Borgen E, Naume B, Jimenez J, Aura CM, Zorzino L, Cassatella MC, Sandri MT, Mostert B, Sleijfer S, Kraan J, Janni W, Fehm T, Rack B, Terstappen L, Repollet M, Pierga JY, Miller C, Sotiriou C, Michiels S, Pantel K
Jaar : 2014
Journal : Breast Cancer Res
Volume : 16(2)
Pagina's : R43

Downregulation of microRNA-24 and -181 parallels the upregulation of IFN-? secreted by activated human CD4 lymphocytes.

Auteurs : Fayyad-Kazan H, Hamade E, Rouas R, Najar M, Fayyad-Kazan M, El Zein N, Eldirani R, Hussein N, Fakhry M, Al-Akoum C, Burny A, Martiat P, Badran B
Jaar : 2014
Journal : Hum Immunol
Volume : 75(7)
Pagina's : 677-85

Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes.

Auteurs : Delforge M, Selleslag D, Beguin Y, Triffet A, Mineur P, Theunissen K, Graux C, Trullemans F, Boulet D, Van Eygen K, Noens L, Van Steenweghen S, Lemmens J, Pierre P, + collaborators (among others :, Ravoet C
Jaar : 2014
Journal : Leuk. Res.
Volume : 38(5)
Pagina's : 557-63

Tumor infiltrating lymphocytes is prognostic and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.

Auteurs : Loi S, Michiels S, Salgado R, Sirtaine N, Jose V, Fumagalli D, Kellokumpu-Lehtinen PL, Bono P, Kataja V, Desmedt C, Piccart-Gebhart M, Loibl S, Denkert C, Smyth MJ, Joensuu H, Sotiriou C
Jaar : 2014
Journal : Ann Oncol
Volume : 25(8)
Pagina's : 1544-50

High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial.

Auteurs : Willemze R, Suciu S, Meloni G, Labar B, Marie JP, Halkes CJ, Muus P, Mistrik M, Amadori S, Specchia G, Fabbiano F, Nobile F, Sborgia M, Camera A, Selleslag DL, Lefrère F, Magro D, Sica S, Cantore N, Beksac M, Berneman Z, Thomas X, Melillo L, Guimaraes JE, Leoni P, Luppi M, Mitra ME, Bron D, Fillet G, Marijt EW, Venditti A, Hagemeijer A, Mancini M, Jansen J, Cilloni D, Meert L, Fazi P, Vignetti M, Trisolini SM, Mandelli F, de Witte T
Jaar : 2014
Journal : J. Clin. Oncol.
Volume : 32(3)
Pagina's : 219-28

Pulmonary Malignancies” “Pulmonary complications of HIV. Edited by Charles Feldman, Eva Polverino, Julio A. Ramirez. ERS/Monograph 66 (chapt 14)

Auteurs : Sculier JP, Meuleman N, Meert AP, Berghmans T
Jaar : 2014
Journal : Book
Volume : chapt 14
Pagina's : 186-198

In vivo production of mesenchymal stromal cells after injection of autologous platelet-rich plasma activated by recombinant human soluble tissue factor in the bone marrow of healthy volunteers.

Auteurs : Philippart P, Meuleman N, Stamatopoulos B, Najar M, Pieters K, De Bruyn C, Bron D, Lagneaux L
Jaar : 2014
Journal : Tissue Eng Part A
Volume : 20(1-2)
Pagina's : 160-70

Rituximab maintenance obviates the poor prognosis associated with circulating lymphoma cells in patients with follicular lymphoma.

Auteurs : Sarkozy C, Seymour JF, Ferme C, Caballero D, Ghesquieres H, Leppa S, Delarue R, Pedersen LM, Mounier C, Gomes Da Silva M, Chassagne-Clement C, Maerevoet M, Salles G
Jaar : 2014
Journal : Blood
Volume : 123(17)
Pagina's : 2740-2

Anemia in the elderly.

Auteurs : Maerevoet M, Sattar L, Bron D, Gulbis B, Pepersack T
Jaar : 2014
Journal : Rev Med Brux
Volume : 35(4)
Pagina's : 361-7

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Auteurs : Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, Van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S
Jaar : 2014
Journal : Lancet Oncol
Volume : 15(4)
Pagina's : 406-14

Myeloperoxidase Oxidized LDL Interferes with Endothelial Cell Motility through miR-22 and Heme Oxygenase 1 Induction: Possible Involvement in Reendothelialization of Vascular Injuries.

Auteurs : Daher J, Martin M, Rousseau A, Nuyens V, Fayyad-Kazan H, Van Antwerpen P, Courbebaisse G, Martiat P, Badran B, Dequiedt F, Zouaoui Boudjeltia K, Vanhamme L
Jaar : 2014
Journal : Mediators Inflamm.
Volume : 2014(null)
Pagina's : 134635

Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients.

Auteurs : Van Damme M, Crompot E, Meuleman N, Mineur P, Dessars B, El Housni H, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2014
Journal : Epigenetics
Volume : 9(10)
Pagina's : 1374-81

Transfer of clinically relevant gene expression signatures in breast cancer: from Affymetrix microarray to Illumina RNA-Sequencing technology.

Auteurs : Fumagalli D, Blanchet-Cohen A, Brown D, Desmedt C, Gacquer D, Michiels S, Rothé F, Majjaj S, Salgado R, Larsimont D, Ignatiadis M, Maetens M, Piccart-Gebhart M, Detours V, Sotiriou C, Haibe-Kains B
Jaar : 2014
Journal : BMC Genomics
Volume : 15(1)
Pagina's : 1008

Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.

Auteurs : Rothé F, Laes JF, Lambrechts D, Smeets D, Vincent D, Maetens M, Fumagalli D, Michiels S, Drisis S, Moerman C, Detiffe JP, Larsimont D, Awada A, Piccart-Gebhart M, Sotiriou C, Ignatiadis M
Jaar : 2014
Journal : Ann Oncol
Volume : 25(10)
Pagina's : 1959-65

Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial.

Auteurs : Demeestere I, Brice P, Peccatori FA, Kentos A, Gaillard I, Zachee P, Casasnovas RO, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Jaar : 2013
Journal : J. Clin. Oncol.
Volume : 31(7)
Pagina's : 903-9

Stem cell transplantation can provide durable disease control in Blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Auteurs : Roos-Weil D, Dietrich S, Boumendil A, Polge E, Bron D, Carreras E, Iriondo Atienza A, Arcese W, Beelen DW, Cornelissen JJ, Kröger N, Milone G, Rossi G, Jardin F, Peters C, Rocha V, Sureda A, Mohty M, Dreger P
Jaar : 2013
Journal : Blood
Volume : 121(3)
Pagina's : 440-446

Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

Auteurs : Ribrag V, Tilly H, Casasnovas O, Bosly A, Bouabdallah R, Delarue R, Boue F, Bron D, Feugier P, Haioun C, Offner F, Coiffier B
Jaar : 2013
Journal : Eur. J. Cancer
Volume : 49(4)
Pagina's : 904-910

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.

Auteurs : Metzger-Filho O, Catteau A, Michiels S, Buyse M, Ignatiadis M, Saini KS, de Azambuja E, Fasolo V, Naji S, Canon JL, Delrée P, Coibion M, Cusumano P, Jossa V, Kains JP, Larsimont D, Richard V, Faverly D, Cornez N, Vuylsteke P, Vanderschueren B, Peyro-Saint-Paul H, Piccart-Gebhart M, Sotiriou C
Jaar : 2013
Journal : PLoS One
Volume : 8(8)
Pagina's : e66848

Pitfalls of monoclonal gammopathy.

Auteurs : Meuleman N
Jaar : 2013
Journal : Rev Med Brux
Volume : 34(4)
Pagina's : 335-8